A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Medium to High Risk Myelofibrosis
Abroad (travel likely)RecruitingPHASE2
Conditions
MF
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
West China Hospital Sichuan University, Chengdu, Sichuan, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), Tianjin, Tianjin Municipality, China
Study leads
Xiao Zhijian
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)
Niu Ting
Principal Investigator
West China Hospital